FCM
NUVB icon

Farallon Capital Management’s Nuvation Bio NUVB Stock Holding History

Farallon Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-29,000
Closed -$124K – 153
2026
Q1 		$124K Hold
29,000
– – ﹤0.01% 160
2025
Q4 		$260K Buy
+29,000
New +$180K ﹤0.01% 120
2023
Q2 		– Sell
-1,465,000
Closed -$2.43M – 179
2023
Q1 		$2.43M Sell
1,465,000
-652,600
-31% -$1.32M 0.01% 135
2022
Q4 		$4.07M Sell
2,117,600
-782,400
-27% -$1.58M 0.02% 156
2022
Q3 		$6.5M Hold
2,900,000
– – 0.04% 166
2022
Q2 		$9.4M Hold
2,900,000
– – 0.05% 141
2022
Q1 		$15.3M Buy
2,900,000
+1,470,000
+103% +$8.26M 0.07% 112
2021
Q4 		$12.2M Sell
1,430,000
-780,000
-35% -$7.17M 0.06% 117
2021
Q3 		$22M Sell
2,210,000
-288,600
-12% -$2.62M 0.1% 98
2021
Q2 		$23.3M Sell
2,498,600
-1,400
-0.1% -$16K 0.1% 95
2021
Q1 		$26.1M Hold
2,500,000
– – 0.13% 93
2020
Q4 		$29.3M Buy
+2,500,000
New +$26M 0.18% 81

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Farallon Capital Management's NUVB Position: Q2 2026 in Review

Farallon Capital Management sold out of Nuvation Bio (NUVB) in Q2 2026, closing a stake of 29,000 shares — an estimated $124K sold.

Farallon Capital Management first reported a position in NUVB in Q4 2020 and held it in 12 quarters. The position peaked at $29.3M in Q4 2020. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Farallon Capital Management reported no remaining Nuvation Bio position as of Q2 2026 after selling out during the quarter.
  • Farallon Capital Management sold 29,000 Nuvation Bio shares in Q2 2026, an estimated $124K.
  • Farallon Capital Management first reported a position in Nuvation Bio in Q4 2020 and held it in 12 quarters.
  • Farallon Capital Management's Nuvation Bio position peaked at $29.3M in Q4 2020.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.